首页 > 最新文献

Global Heart最新文献

英文 中文
Unstable Angina: Risk Stratification for Significant Coronary Artery Disease in The Era of High-Sensitivity Cardiac Troponin. 不稳定型心绞痛:高敏心肌肌钙蛋白时代重大冠状动脉疾病的风险分层。
IF 3 3区 医学 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-01-19 eCollection Date: 2024-01-01 DOI: 10.5334/gh.1286
Luis Paiva, Maria João Vieira, Rui Baptista, Maria João Ferreira, Lino Gonçalves

Introduction: High-sensitivity troponin (hsTn) has a very high diagnostic accuracy for myocardial infarction (MI), and patients who were formerly diagnosed with unstable angina (UA) are being reclassified as having NSTEMI in the era of hsTn. This paradigm shift has changed the clinical features of UA, which remain poorly characterized, specifically the occurrence of obstructive coronary artery disease (CAD) and the need for myocardial revascularization. The main purpose of this study was to clinically characterize contemporary UA patients, assess predictors of obstructive CAD, and develop a risk model to predict significant CAD in this population.

Methods: We conducted a retrospective cohort study of 742 patients admitted to the hospital with UA. All patients underwent coronary angiography. The endpoint of the study was the presence of obstructive CAD on angiography. The cohort was divided into two groups: patients with significant coronary artery disease (CAD+) and those without CAD (CAD-). We developed a score (UA CAD Risk) based on the multivariate model and compared it with the GRACE, ESC, and TIMI risk scores using ROC analysis.

Results: Obstructive CAD was observed on angiography in 53% of the patients. Age, dyslipidemia, troponin level, male sex, ST-segment depression, and wall motion abnormalities on echocardiography were independent predictors of obstructive CAD. hsTn levels (undetectable vs. nonsignificant detection) had a negative predictive value of 81% to exclude obstructive CAD. We developed a prediction model with obstructive CAD as the outcome (AUC: 0.60).

Conclusions: In a contemporary UA cohort, approximately 50% of the patients did not have obstructive CAD on angiography. Commonly available cardiac tests at hospital admission show limited discrimination power in identifying patients at risk of obstructive CAD. A revised diagnostic and etiology algorithm for patients with UA is warranted.

导言:高敏肌钙蛋白(hsTn)对心肌梗死(MI)的诊断准确率非常高,在使用 hsTn 的时代,以前被诊断为不稳定型心绞痛(UA)的患者正在被重新归类为 NSTEMI。这种模式的转变改变了不稳定型心绞痛的临床特征,尤其是阻塞性冠状动脉疾病(CAD)的发生和心肌血运重建的需要,而这些特征仍然没有得到很好的描述。本研究的主要目的是了解当代 UA 患者的临床特征,评估阻塞性 CAD 的预测因素,并建立一个风险模型来预测该人群中的重大 CAD:我们对入院的 742 名 UA 患者进行了回顾性队列研究。所有患者均接受了冠状动脉造影术。研究的终点是血管造影中是否存在阻塞性 CAD。研究对象被分为两组:有明显冠状动脉疾病的患者(CAD+)和无冠状动脉疾病的患者(CAD-)。我们根据多变量模型制定了一个评分(UA CAD 风险),并通过 ROC 分析将其与 GRACE、ESC 和 TIMI 风险评分进行了比较:结果:53%的患者在血管造影中观察到阻塞性 CAD。年龄、血脂异常、肌钙蛋白水平、男性、ST段压低和超声心动图室壁运动异常是阻塞性 CAD 的独立预测因素。我们建立了一个以阻塞性 CAD 为结果的预测模型(AUC:0.60):结论:在当代 UA 队列中,约 50% 的患者在血管造影检查中没有发现阻塞性 CAD。入院时常见的心脏检查在识别有阻塞性冠状动脉粥样硬化风险的患者方面显示出有限的鉴别力。有必要对 UA 患者的诊断和病因算法进行修订。
{"title":"Unstable Angina: Risk Stratification for Significant Coronary Artery Disease in The Era of High-Sensitivity Cardiac Troponin.","authors":"Luis Paiva, Maria João Vieira, Rui Baptista, Maria João Ferreira, Lino Gonçalves","doi":"10.5334/gh.1286","DOIUrl":"10.5334/gh.1286","url":null,"abstract":"<p><strong>Introduction: </strong>High-sensitivity troponin (hsTn) has a very high diagnostic accuracy for myocardial infarction (MI), and patients who were formerly diagnosed with unstable angina (UA) are being reclassified as having NSTEMI in the era of hsTn. This paradigm shift has changed the clinical features of UA, which remain poorly characterized, specifically the occurrence of obstructive coronary artery disease (CAD) and the need for myocardial revascularization. The main purpose of this study was to clinically characterize contemporary UA patients, assess predictors of obstructive CAD, and develop a risk model to predict significant CAD in this population.</p><p><strong>Methods: </strong>We conducted a retrospective cohort study of 742 patients admitted to the hospital with UA. All patients underwent coronary angiography. The endpoint of the study was the presence of obstructive CAD on angiography. The cohort was divided into two groups: patients with significant coronary artery disease (CAD<sup>+</sup>) and those without CAD (CAD<sup>-</sup>). We developed a score (UA CAD Risk) based on the multivariate model and compared it with the GRACE, ESC, and TIMI risk scores using ROC analysis.</p><p><strong>Results: </strong>Obstructive CAD was observed on angiography in 53% of the patients. Age, dyslipidemia, troponin level, male sex, ST-segment depression, and wall motion abnormalities on echocardiography were independent predictors of obstructive CAD. hsTn levels (undetectable vs. nonsignificant detection) had a negative predictive value of 81% to exclude obstructive CAD. We developed a prediction model with obstructive CAD as the outcome (AUC: 0.60).</p><p><strong>Conclusions: </strong>In a contemporary UA cohort, approximately 50% of the patients did not have obstructive CAD on angiography. Commonly available cardiac tests at hospital admission show limited discrimination power in identifying patients at risk of obstructive CAD. A revised diagnostic and etiology algorithm for patients with UA is warranted.</p>","PeriodicalId":56018,"journal":{"name":"Global Heart","volume":"19 1","pages":"7"},"PeriodicalIF":3.0,"publicationDate":"2024-01-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10798171/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139514089","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Sex Differences in the Primary Prevention of Cardiovascular Diseases in a Dutch Primary Care Setting. 荷兰初级医疗机构中心血管疾病初级预防的性别差异。
IF 3 3区 医学 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-01-19 eCollection Date: 2024-01-01 DOI: 10.5334/gh.1284
Pauline A J Kiss, Alicia Uijl, Estefania Betancur, Annemarijn R de Boer, Diederick E Grobbee, Monika Hollander, Charlotte N Onland-Moret, Miriam C J M Sturkenboom, Sanne A E Peters

Background: Sex differences in the primary prevention of cardiovascular diseases (CVD) have been shown, but the evidence is mixed and fragmented. In this study, we assessed sex differences in cardiovascular risk factors assessment, risk factor levels, treatment, and meeting of treatment targets, within a Dutch primary care setting.

Methods: Data were obtained from individuals aged 40 to 70 years old, without prior CVD, registered during the entire year in 2018 at one of the 51 general practices participating in the Julius General Practitioner's Network (JGPN). History of CVD was defined based on the International Classification of Primary Care (ICPC). Linear and Poisson regressions were used to investigate sex differences in risk factor assessment, risk factor levels, treatment, and meeting of treatment targets.

Results: We included 83,903 individuals (50% women). With the exception of glycated hemoglobin (HbA1c), all risk factors for CVD were more often measured in women than in men. Lipid measurements and body mass index values were higher in women, while blood pressure (BP) and HbA1c levels were higher in men, along with estimated glomerular filtration rate (eGFR) levels. Among individuals with elevated BP or cholesterol levels, no sex difference was observed in the prescription of antihypertensive medications (RR 1.00, 95% CI: 0.94-1.06) but women were less likely than men to receive lipid-lowering medications (RR 0.87, 95% CI: 0.79-0.95). Among treated individuals, women were more likely than men to meet adequate levels of blood pressure (RR 1.17, 95% CI: 1.09-1.25) and less likely to meet target levels of cholesterol (RR 0.90, 95% CI: 0.83-0.98).

Conclusion: While women were more likely to have their CVD risk factors measured, they were less likely to be prescribed lipid-lowering medications and to meet target levels. When treated, men were less likely to achieve adequate blood pressure control.

背景:心血管疾病(CVD)一级预防中的性别差异已经显现,但证据不一且零散。在这项研究中,我们评估了荷兰初级医疗机构在心血管风险因素评估、风险因素水平、治疗和达到治疗目标方面的性别差异:数据来自年龄在 40 岁至 70 岁之间、无心血管疾病史、2018 年全年在参与朱利叶斯全科医师网络(JGPN)的 51 家全科诊所之一登记的个人。心血管病史的定义基于国际初级保健分类(ICPC)。我们使用线性回归和泊松回归来研究风险因素评估、风险因素水平、治疗和达到治疗目标方面的性别差异:我们纳入了 83903 人(50% 为女性)。除糖化血红蛋白(HbA1c)外,女性比男性更常测量心血管疾病的所有危险因素。女性的血脂测量值和体重指数值较高,而男性的血压(BP)和 HbA1c 水平以及估计肾小球滤过率(eGFR)水平较高。在血压或胆固醇水平升高的人群中,降压药的处方没有性别差异(RR 1.00,95% CI:0.94-1.06),但女性接受降脂药的可能性低于男性(RR 0.87,95% CI:0.79-0.95)。在接受治疗的患者中,女性比男性更有可能达到适当的血压水平(RR 1.17,95% CI:1.09-1.25),而达到目标胆固醇水平的可能性较低(RR 0.90,95% CI:0.83-0.98):结论:虽然女性更有可能接受心血管疾病风险因素的测量,但她们获得降脂药物处方和达到目标水平的可能性较低。在接受治疗时,男性获得适当血压控制的可能性较低。
{"title":"Sex Differences in the Primary Prevention of Cardiovascular Diseases in a Dutch Primary Care Setting.","authors":"Pauline A J Kiss, Alicia Uijl, Estefania Betancur, Annemarijn R de Boer, Diederick E Grobbee, Monika Hollander, Charlotte N Onland-Moret, Miriam C J M Sturkenboom, Sanne A E Peters","doi":"10.5334/gh.1284","DOIUrl":"10.5334/gh.1284","url":null,"abstract":"<p><strong>Background: </strong>Sex differences in the primary prevention of cardiovascular diseases (CVD) have been shown, but the evidence is mixed and fragmented. In this study, we assessed sex differences in cardiovascular risk factors assessment, risk factor levels, treatment, and meeting of treatment targets, within a Dutch primary care setting.</p><p><strong>Methods: </strong>Data were obtained from individuals aged 40 to 70 years old, without prior CVD, registered during the entire year in 2018 at one of the 51 general practices participating in the Julius General Practitioner's Network (JGPN). History of CVD was defined based on the International Classification of Primary Care (ICPC). Linear and Poisson regressions were used to investigate sex differences in risk factor assessment, risk factor levels, treatment, and meeting of treatment targets.</p><p><strong>Results: </strong>We included 83,903 individuals (50% women). With the exception of glycated hemoglobin (HbA1c), all risk factors for CVD were more often measured in women than in men. Lipid measurements and body mass index values were higher in women, while blood pressure (BP) and HbA1c levels were higher in men, along with estimated glomerular filtration rate (eGFR) levels. Among individuals with elevated BP or cholesterol levels, no sex difference was observed in the prescription of antihypertensive medications (RR 1.00, 95% CI: 0.94-1.06) but women were less likely than men to receive lipid-lowering medications (RR 0.87, 95% CI: 0.79-0.95). Among treated individuals, women were more likely than men to meet adequate levels of blood pressure (RR 1.17, 95% CI: 1.09-1.25) and less likely to meet target levels of cholesterol (RR 0.90, 95% CI: 0.83-0.98).</p><p><strong>Conclusion: </strong>While women were more likely to have their CVD risk factors measured, they were less likely to be prescribed lipid-lowering medications and to meet target levels. When treated, men were less likely to achieve adequate blood pressure control.</p>","PeriodicalId":56018,"journal":{"name":"Global Heart","volume":"19 1","pages":"6"},"PeriodicalIF":3.0,"publicationDate":"2024-01-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10798167/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139514078","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Edema Index Predicts Mortality in Patients with Chronic Heart Failure: A Prospective, Observational Study. 水肿指数可预测慢性心力衰竭患者的死亡率:一项前瞻性观察研究
IF 3 3区 医学 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-01-18 eCollection Date: 2024-01-01 DOI: 10.5334/gh.1287
Bryan Richard Sasmita, Yuhe Zhao, Ming Gong, Suxin Luo, Bi Huang

Introduction: Chronic fluid accumulation or congestion is considered an important pathophysiologic mechanism in heart failure, leading to cardinal symptoms such as dyspnea, pulmonary congestion, and pitting edema. Edema index (EI) recently emerged as a surrogate for extracellular volume status and has been proven to be able to reflect one's congestion status. In this study, we aimed to evaluate the prognostic value of EI in patients with chronic heart failure (CHF).

Methods: A total of 401 consecutive patients with CHF between August 2019 and October 2021 were prospectively enrolled. EI was obtained by InBody S10. The primary endpoint was long-term all-cause and cardiovascular mortality.

Results: Patients with high EI (>0.397) tended to be older, presented with atrial fibrillation, have higher N-terminal brain natriuretic peptide, and have higher creatinine (all p < 0.05). During a median follow-up of 1200 days, the all-cause and cardiovascular mortality rate was significantly higher in the high EI group compared to the low EI group (all-cause mortality rate 43.8% vs. 30.3%, p < 0.001, and cardiovascular mortality rate 17.5% vs. 13.0%, p < 0.001, respectively). In the multivariate Cox proportional hazard analysis, EI > 0.397 was an independent predictor for both all-cause mortality (HR 1.959; 95% CI 1.304, 2.944; p = 0.001) and cardiovascular mortality (HR 2.051; 95% CI 1.276, 3.296; p = 0.003).

Conclusions: Admission EI could be used as a marker for predicting long-term mortality in patients with CHF, and higher EI was associated with an increased risk of all-cause and cardiovascular mortality. Furthermore, EI-guided management could be a promising therapy in patients with CHF.

前言慢性液体积聚或充血被认为是心力衰竭的重要病理生理机制,会导致呼吸困难、肺充血和点状水肿等主要症状。最近,水肿指数(EI)作为细胞外容量状态的替代指标出现,并被证明能够反映一个人的充血状态。本研究旨在评估 EI 在慢性心力衰竭(CHF)患者中的预后价值:方法:我们前瞻性地纳入了 2019 年 8 月至 2021 年 10 月期间的 401 名连续 CHF 患者。EI 由 InBody S10 采集。主要终点是长期全因死亡率和心血管死亡率:EI值高(>0.397)的患者往往年龄较大、伴有心房颤动、N末端脑钠肽较高、肌酐较高(P均<0.05)。在中位随访 1200 天期间,高 EI 组的全因死亡率和心血管死亡率明显高于低 EI 组(全因死亡率分别为 43.8% 对 30.3%,P < 0.001;心血管死亡率分别为 17.5% 对 13.0%,P < 0.001)。在多变量 Cox 比例危险分析中,EI > 0.397 是全因死亡率(HR 1.959; 95% CI 1.304, 2.944; p = 0.001)和心血管死亡率(HR 2.051; 95% CI 1.276, 3.296; p = 0.003)的独立预测因子:入院EI可作为预测CHF患者长期死亡率的指标,EI越高,全因死亡率和心血管死亡率风险越高。此外,以 EI 为指导的治疗对慢性阻塞性肺病患者来说是一种很有前景的疗法。
{"title":"Edema Index Predicts Mortality in Patients with Chronic Heart Failure: A Prospective, Observational Study.","authors":"Bryan Richard Sasmita, Yuhe Zhao, Ming Gong, Suxin Luo, Bi Huang","doi":"10.5334/gh.1287","DOIUrl":"10.5334/gh.1287","url":null,"abstract":"<p><strong>Introduction: </strong>Chronic fluid accumulation or congestion is considered an important pathophysiologic mechanism in heart failure, leading to cardinal symptoms such as dyspnea, pulmonary congestion, and pitting edema. Edema index (EI) recently emerged as a surrogate for extracellular volume status and has been proven to be able to reflect one's congestion status. In this study, we aimed to evaluate the prognostic value of EI in patients with chronic heart failure (CHF).</p><p><strong>Methods: </strong>A total of 401 consecutive patients with CHF between August 2019 and October 2021 were prospectively enrolled. EI was obtained by InBody S10. The primary endpoint was long-term all-cause and cardiovascular mortality.</p><p><strong>Results: </strong>Patients with high EI (>0.397) tended to be older, presented with atrial fibrillation, have higher N-terminal brain natriuretic peptide, and have higher creatinine (all p < 0.05). During a median follow-up of 1200 days, the all-cause and cardiovascular mortality rate was significantly higher in the high EI group compared to the low EI group (all-cause mortality rate 43.8% vs. 30.3%, p < 0.001, and cardiovascular mortality rate 17.5% vs. 13.0%, p < 0.001, respectively). In the multivariate Cox proportional hazard analysis, EI > 0.397 was an independent predictor for both all-cause mortality (HR 1.959; 95% CI 1.304, 2.944; p = 0.001) and cardiovascular mortality (HR 2.051; 95% CI 1.276, 3.296; p = 0.003).</p><p><strong>Conclusions: </strong>Admission EI could be used as a marker for predicting long-term mortality in patients with CHF, and higher EI was associated with an increased risk of all-cause and cardiovascular mortality. Furthermore, EI-guided management could be a promising therapy in patients with CHF.</p>","PeriodicalId":56018,"journal":{"name":"Global Heart","volume":"19 1","pages":"5"},"PeriodicalIF":3.0,"publicationDate":"2024-01-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10798169/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139514077","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical Outcome of Rheumatic Mitral Valve Repair and Replacement Surgery in Indonesia; A Comparison with Non-Rheumatic Aetiology 印度尼西亚风湿性二尖瓣修复和置换手术的临床效果;与非风湿性病因的比较
IF 3.7 3区 医学 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-01-11 DOI: 10.5334/gh.1285
AmilianaMardiani Soesanto, E. Rudiktyo, Amin Tjubandi, R. Ariani, Fadhila Nafilah Azzahra, Mochammad Faisal Adam, A. Kuncoro
Introduction: Mitral valve repair (MVr) has been shown to achieve better outcomes than mitral valve replacement (MVR) in degenerative aetiology. However, that cannot be applied in rheumatic mitral valve disease. Therefore, this study aims to evaluate early and late clinical outcomes and mid-term survival in RHD compared to the non-RHD group and whether mitral valve repair is a better surgical approach in RHD patients. Methods: Patients who underwent mitral valve surgery with or without coronary artery bypass grafting were included in this study. All patients were divided into the RHD and non-RHD group by the type of mitral surgery performed. Early and late outcomes were evaluated, and mid-term cumulative survival was reported. Results: A total of 1382 patients post MV surgeries were included. The 30-day mortality was significantly higher in the RHD group compared to the non-RHD group (8.7% vs. 4.4%, p = 0.003). There was no difference in 30-day mortality between repair and replacement in each respective group. During follow-up (12–54 months), all-cause mortality between RHD and non-RHD groups (16.7% vs. 16.2%) was not different. In the RHD group, the survival of MVr was 85.6% (95% CI 82.0%–88.5%), and MVR was 78.3% (95% CI 75.8%–80.6%), p-value log rank 0.26 However, in the non-RHD group, patients who underwent MVr had better survival than MVR, with cumulative survival of 81.7% (95% CI 72.3%–88.2%) vs. 71.1% (95% CI 56.3%–81.7%) p-value log rank 0.007. Conclusion: Early mortality rate in rheumatic mitral valve surgery was higher than in non-rheumatic valve surgery. Although in rheumatic MV disease MV repair did not show a significant survival advantage over MV replacement, a trend towards more favourable survival in the repair group was observed.
导言:在退行性病因中,二尖瓣修复术(MVr)的疗效优于二尖瓣置换术(MVR)。然而,这并不适用于风湿性二尖瓣疾病。因此,本研究旨在评估风湿性二尖瓣狭窄(RHD)与非风湿性二尖瓣狭窄(RHD)组相比的早期、晚期临床疗效和中期生存率,以及二尖瓣修复术是否是风湿性二尖瓣狭窄(RHD)患者更好的手术方法。研究方法本研究纳入了接受或未接受冠状动脉旁路移植手术的二尖瓣手术患者。根据二尖瓣手术的类型将所有患者分为RHD组和非RHD组。对早期和晚期结果进行评估,并报告中期累积存活率。研究结果共纳入了 1382 名接受二尖瓣手术的患者。与非 RHD 组相比,RHD 组的 30 天死亡率明显更高(8.7% 对 4.4%,P = 0.003)。修复组和置换组的 30 天死亡率没有差异。在随访期间(12-54 个月),RHD 组和非 RHD 组的全因死亡率(16.7% 对 16.2%)没有差异。在 RHD 组中,MVr 的存活率为 85.6%(95% CI 82.0%-88.5%),MVR 为 78.3%(95% CI 75.8%-80.6%),P 值对数等级为 0.26,但在非 RHD 组中,接受 MVr 的患者的存活率高于 MVR,累计存活率为 81.7%(95% CI 72.3%-88.2%)vs 71.1%(95% CI 56.3%-81.7%),P 值对数等级为 0.007。结论风湿性二尖瓣手术的早期死亡率高于非风湿性瓣膜手术。虽然在风湿性二尖瓣疾病中,二尖瓣修复术与二尖瓣置换术相比并没有显示出明显的生存优势,但修复组的生存率呈上升趋势。
{"title":"Clinical Outcome of Rheumatic Mitral Valve Repair and Replacement Surgery in Indonesia; A Comparison with Non-Rheumatic Aetiology","authors":"AmilianaMardiani Soesanto, E. Rudiktyo, Amin Tjubandi, R. Ariani, Fadhila Nafilah Azzahra, Mochammad Faisal Adam, A. Kuncoro","doi":"10.5334/gh.1285","DOIUrl":"https://doi.org/10.5334/gh.1285","url":null,"abstract":"Introduction: Mitral valve repair (MVr) has been shown to achieve better outcomes than mitral valve replacement (MVR) in degenerative aetiology. However, that cannot be applied in rheumatic mitral valve disease. Therefore, this study aims to evaluate early and late clinical outcomes and mid-term survival in RHD compared to the non-RHD group and whether mitral valve repair is a better surgical approach in RHD patients. Methods: Patients who underwent mitral valve surgery with or without coronary artery bypass grafting were included in this study. All patients were divided into the RHD and non-RHD group by the type of mitral surgery performed. Early and late outcomes were evaluated, and mid-term cumulative survival was reported. Results: A total of 1382 patients post MV surgeries were included. The 30-day mortality was significantly higher in the RHD group compared to the non-RHD group (8.7% vs. 4.4%, p = 0.003). There was no difference in 30-day mortality between repair and replacement in each respective group. During follow-up (12–54 months), all-cause mortality between RHD and non-RHD groups (16.7% vs. 16.2%) was not different. In the RHD group, the survival of MVr was 85.6% (95% CI 82.0%–88.5%), and MVR was 78.3% (95% CI 75.8%–80.6%), p-value log rank 0.26 However, in the non-RHD group, patients who underwent MVr had better survival than MVR, with cumulative survival of 81.7% (95% CI 72.3%–88.2%) vs. 71.1% (95% CI 56.3%–81.7%) p-value log rank 0.007. Conclusion: Early mortality rate in rheumatic mitral valve surgery was higher than in non-rheumatic valve surgery. Although in rheumatic MV disease MV repair did not show a significant survival advantage over MV replacement, a trend towards more favourable survival in the repair group was observed.","PeriodicalId":56018,"journal":{"name":"Global Heart","volume":"8 21","pages":""},"PeriodicalIF":3.7,"publicationDate":"2024-01-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139438105","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
New Insights into Rate Control: Time in Target Range of Resting Heart Rate and Major Adverse Outcomes in Atrial Fibrillation 对心率控制的新认识:静息心率目标范围内的时间与心房颤动的主要不良后果
IF 3.7 3区 医学 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-01-11 DOI: 10.5334/gh.1251
Yuhui Lai, Xingfeng Xu, Shaozhao Zhang, R. Huang, Yiquan Huang, Xiangbin Zhong, Z. Xiong, Yifen Lin, Hui-min Zhou, Yue Guo, X. Liao, Yuedong Ma, X. Zhuang
Background: Few studies have examined the relationship between the fluctuation of heart rate control over time and cardiovascular outcomes in patients with atrial fibrillation. Our study sought to evaluate the independent association between time in target range (TIR) of resting heart rate and cardiovascular outcomes in the AFFIRM (Atrial Fibrillation Follow-Up Investigation of Rhythm Management) study. Methods: Target range of resting heart was defined as less than 80 beats per minute (bpm) for both rate and rhythm control groups. Time in target range was estimated over the first 8 months of follow-up using Rosendaal interpolation method. The association between TIR of resting heart rate and cardiovascular outcomes was estimated using adjusted Cox proportional hazards regression models. Results: Time in target range of resting heart rate (months 0 through 8) was 71 ± 34% in the rate control group and 83 ± 27% in the rhythm control group. Each 1-SD increase in TIR of resting heart rate was significantly associated with lower risk of major adverse cardiovascular events after full adjustment for demographics, medical history and history of prior heart surgery, as well as all-cause mortality. Conclusions: Time in target range of resting heart rate independently predicts the risk of cardiovascular outcomes in patients with atrial fibrillation. Long-term maintenance of heart rate on target is of great importance for patients with atrial fibrillation.
背景:很少有研究探讨心房颤动患者心率控制随时间的波动与心血管预后之间的关系。我们的研究旨在评估 AFFIRM(心房颤动节律管理随访调查)研究中静息心率在目标范围内的时间(TIR)与心血管预后之间的独立关联。研究方法心率控制组和心律控制组的静息心率目标范围均定义为低于每分钟 80 次(bpm)。在随访的前 8 个月中,使用 Rosendaal 插值法估算目标范围内的时间。采用调整后的考克斯比例危险回归模型估算静息心率目标范围与心血管疾病结果之间的关系。结果静息心率在目标范围内的时间(0 至 8 个月),心率控制组为 71 ± 34%,心律控制组为 83 ± 27%。在对人口统计学、病史和既往心脏手术史以及全因死亡率进行全面调整后,静息心率目标范围每增加 1 个分度,主要不良心血管事件的风险就会显著降低。结论静息心率在目标范围内的时间可独立预测心房颤动患者的心血管后果风险。长期保持心率在目标范围内对心房颤动患者非常重要。
{"title":"New Insights into Rate Control: Time in Target Range of Resting Heart Rate and Major Adverse Outcomes in Atrial Fibrillation","authors":"Yuhui Lai, Xingfeng Xu, Shaozhao Zhang, R. Huang, Yiquan Huang, Xiangbin Zhong, Z. Xiong, Yifen Lin, Hui-min Zhou, Yue Guo, X. Liao, Yuedong Ma, X. Zhuang","doi":"10.5334/gh.1251","DOIUrl":"https://doi.org/10.5334/gh.1251","url":null,"abstract":"Background: Few studies have examined the relationship between the fluctuation of heart rate control over time and cardiovascular outcomes in patients with atrial fibrillation. Our study sought to evaluate the independent association between time in target range (TIR) of resting heart rate and cardiovascular outcomes in the AFFIRM (Atrial Fibrillation Follow-Up Investigation of Rhythm Management) study. Methods: Target range of resting heart was defined as less than 80 beats per minute (bpm) for both rate and rhythm control groups. Time in target range was estimated over the first 8 months of follow-up using Rosendaal interpolation method. The association between TIR of resting heart rate and cardiovascular outcomes was estimated using adjusted Cox proportional hazards regression models. Results: Time in target range of resting heart rate (months 0 through 8) was 71 ± 34% in the rate control group and 83 ± 27% in the rhythm control group. Each 1-SD increase in TIR of resting heart rate was significantly associated with lower risk of major adverse cardiovascular events after full adjustment for demographics, medical history and history of prior heart surgery, as well as all-cause mortality. Conclusions: Time in target range of resting heart rate independently predicts the risk of cardiovascular outcomes in patients with atrial fibrillation. Long-term maintenance of heart rate on target is of great importance for patients with atrial fibrillation.","PeriodicalId":56018,"journal":{"name":"Global Heart","volume":"5 10","pages":""},"PeriodicalIF":3.7,"publicationDate":"2024-01-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139438477","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Correction: COVID-19 Vaccine-Induced Myocarditis and Pericarditis: Towards Identification of Risk Factors 更正:COVID-19 疫苗诱发的心肌炎和心包炎:识别风险因素
IF 3.7 3区 医学 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-01-08 DOI: 10.5334/gh.1276
Laura C. Zwiers, David S. Y. Ong, D. Grobbee
This article details a correction to: Zwiers LC, Ong DSY, Grobbee DE. COVID-19 Vaccine-Induced Myocarditis and Pericarditis: Towards Identification of Risk Factors. Global Heart. 2023; 18(1): 39. DOI: https://doi.org/10.5334/gh.1252
本文详细介绍了对Zwiers LC, Ong DSY, Grobbee DE.COVID-19 疫苗诱发的心肌炎和心包炎:风险因素的识别》。全球心脏。2023; 18(1):39.DOI: https://doi.org/10.5334/gh.1252
{"title":"Correction: COVID-19 Vaccine-Induced Myocarditis and Pericarditis: Towards Identification of Risk Factors","authors":"Laura C. Zwiers, David S. Y. Ong, D. Grobbee","doi":"10.5334/gh.1276","DOIUrl":"https://doi.org/10.5334/gh.1276","url":null,"abstract":"This article details a correction to: Zwiers LC, Ong DSY, Grobbee DE. COVID-19 Vaccine-Induced Myocarditis and Pericarditis: Towards Identification of Risk Factors. Global Heart. 2023; 18(1): 39. DOI: https://doi.org/10.5334/gh.1252","PeriodicalId":56018,"journal":{"name":"Global Heart","volume":"53 50","pages":""},"PeriodicalIF":3.7,"publicationDate":"2024-01-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139447214","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Burden of Chagas Disease in the Contemporary World: The RAISE Study 恰加斯病在当代世界的负担:RAISE 研究
IF 3.7 3区 医学 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-01-08 DOI: 10.5334/gh.1280
A. L. P. Ribeiro
Chagas disease (ChD), a Neglected Tropical Disease, has witnessed a transformative epidemiological landscape characterized by a trend of reduction in prevalence, shifting modes of transmission, urbanization, and globalization. Historically a vector-borne disease in rural areas of Latin America, effective control measures have reduced the incidence in many countries, leading to a demographic shift where most affected individuals are now adults. However, challenges persist in regions like the Gran Chaco, and emerging oral transmission in the Amazon basin adds complexity. Urbanization and migration from rural to urban areas and to non-endemic countries, especially in Europe and the US, have redefined the disease’s reach. These changing patterns contribute to uncertainties in estimating ChD prevalence, exacerbated by the lack of recent data, scarcity of surveys, and reliance on outdated models. Besides, ChD’s lifelong natural history, marked by acute and chronic phases, introduces complexities in diagnosis, particularly in non-endemic regions where healthcare provider awareness is low. The temporal dissociation of infection and clinical manifestations, coupled with underreporting, has rendered ChD invisible in health statistics. Deaths attributed to ChD cardiomyopathy often go unrecognized, camouflaged under alternative causes. Understanding these challenges, the RAISE project aims to reassess the burden of ChD and ChD cardiomyopathy. The project is a collaborative effort of the World Heart Federation, Novartis Global Health, the University of Washington’s Institute for Health Metrics and Evaluation, and a team of specialists coordinated by Brazil’s Federal University of Minas Gerais. Employing a multidimensional strategy, the project seeks to refine estimates of ChD-related deaths, conduct systematic reviews on seroprevalence and prevalence of clinical forms, enhance existing modeling frameworks, and calculate the global economic burden, considering healthcare expenditures and service access. The RAISE project aspires to bridge knowledge gaps, raise awareness, and inform evidence-based health policies and research initiatives, positioning ChD prominently on the global health agenda.
南美锥虫病(ChD)是一种被忽视的热带疾病,它的流行病学状况正在发生变化,其特点是发病率呈下降趋势、传播方式发生转变、城市化和全球化。在拉丁美洲的农村地区,该病历来是一种病媒传播疾病,有效的控制措施降低了许多国家的发病率,导致人口结构发生变化,现在大多数患者都是成年人。然而,在大查科等地区,挑战依然存在,亚马逊盆地新出现的口腔传播也增加了复杂性。城市化以及从农村向城市地区和非流行国家(尤其是欧洲和美国)的迁移重新界定了该疾病的传播范围。这些不断变化的模式导致在估算 ChD 流行率时存在不确定性,而近期数据的缺乏、调查的匮乏以及对过时模型的依赖又加剧了这种不确定性。此外,ChD 的自然病史是终身的,分为急性期和慢性期,这给诊断带来了复杂性,尤其是在医疗服务提供者意识薄弱的非流行地区。感染与临床表现在时间上的分离,再加上报告不足,使得 ChD 在卫生统计中被忽视。因 ChD 心肌病导致的死亡往往不被承认,被掩盖在其他病因之下。了解到这些挑战后,RAISE 项目旨在重新评估 ChD 和 ChD 心肌病的负担。该项目由世界心脏病联盟、诺华全球健康公司、华盛顿大学健康度量与评估研究所以及由巴西米纳斯吉拉斯联邦大学协调的专家团队合作开展。该项目采用多维战略,旨在完善与慢性阻塞性肺病相关的死亡人数估算,对血清流行率和临床形式的流行率进行系统回顾,加强现有的建模框架,并计算全球经济负担,同时考虑医疗保健支出和服务获取情况。RAISE 项目旨在弥补知识差距、提高认识并为循证卫生政策和研究计划提供信息,从而将慢性阻塞性肺病置于全球卫生议程的突出位置。
{"title":"The Burden of Chagas Disease in the Contemporary World: The RAISE Study","authors":"A. L. P. Ribeiro","doi":"10.5334/gh.1280","DOIUrl":"https://doi.org/10.5334/gh.1280","url":null,"abstract":"Chagas disease (ChD), a Neglected Tropical Disease, has witnessed a transformative epidemiological landscape characterized by a trend of reduction in prevalence, shifting modes of transmission, urbanization, and globalization. Historically a vector-borne disease in rural areas of Latin America, effective control measures have reduced the incidence in many countries, leading to a demographic shift where most affected individuals are now adults. However, challenges persist in regions like the Gran Chaco, and emerging oral transmission in the Amazon basin adds complexity. Urbanization and migration from rural to urban areas and to non-endemic countries, especially in Europe and the US, have redefined the disease’s reach. These changing patterns contribute to uncertainties in estimating ChD prevalence, exacerbated by the lack of recent data, scarcity of surveys, and reliance on outdated models. Besides, ChD’s lifelong natural history, marked by acute and chronic phases, introduces complexities in diagnosis, particularly in non-endemic regions where healthcare provider awareness is low. The temporal dissociation of infection and clinical manifestations, coupled with underreporting, has rendered ChD invisible in health statistics. Deaths attributed to ChD cardiomyopathy often go unrecognized, camouflaged under alternative causes. Understanding these challenges, the RAISE project aims to reassess the burden of ChD and ChD cardiomyopathy. The project is a collaborative effort of the World Heart Federation, Novartis Global Health, the University of Washington’s Institute for Health Metrics and Evaluation, and a team of specialists coordinated by Brazil’s Federal University of Minas Gerais. Employing a multidimensional strategy, the project seeks to refine estimates of ChD-related deaths, conduct systematic reviews on seroprevalence and prevalence of clinical forms, enhance existing modeling frameworks, and calculate the global economic burden, considering healthcare expenditures and service access. The RAISE project aspires to bridge knowledge gaps, raise awareness, and inform evidence-based health policies and research initiatives, positioning ChD prominently on the global health agenda.","PeriodicalId":56018,"journal":{"name":"Global Heart","volume":"12 5","pages":""},"PeriodicalIF":3.7,"publicationDate":"2024-01-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139445623","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Socioecological Factors Associated with Hypertension Awareness and Control Among Older Adults in Brazil and Colombia: Correlational Analysis from the International Mobility in Aging Study. 与巴西和哥伦比亚老年人高血压意识和控制有关的社会生态因素:国际老龄流动性研究的相关分析》。
IF 3 3区 医学 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2023-12-26 eCollection Date: 2023-01-01 DOI: 10.5334/gh.1282
Catherine M Pirkle, Ricardo Oliveira Guerra, Fernando Gómez, Emmanuelle Belanger, Tetine Sentell

Background: Hypertension awareness and control are understudied among older adults in middle-income countries, with limited work contextualizing awareness and control across layers of influence (individual to the community). Research on hypertension in Latin America is acknowledged as insufficient.

Objectives: This study applies the socioecological model (SEM) to examine individual, interpersonal, institutional, and community factors related to hypertension awareness and control in older adults residing in Brazil and Colombia. It identifies groups of older adults more likely to be unaware of their condition and/or to have challenges achieving hypertension control.

Methods: We analyzed International Mobility in Aging Study data of 803 community-dwelling adults 65-74 years from study sites in the two most populous countries in South America. The study framework was the socioecological model. Logistic regression models identified factors associated with hypertension awareness and control.

Conclusions: Hypertension was prevalent in both samples (>70%), and awareness was high (>80%). Blood pressure control among diagnosed respondents was low: 30% in Brazil and 51% in Colombia. Factors across the socioecological model were associated with awareness and control, with notable differences across countries. Those with diabetes (OR 4.19, 95%CI 1.64-10.71) and insufficient incomes (OR: 1.85, 95%CI 1.03-3.31) were more likely to be aware of their hypertension. In Colombia, those reporting no community activity engagement were less likely to be aware compared to those reporting community activities. In Brazil, it was the opposite. Women (OR 1.66, 95%CI 1.12-2.46) and those reporting strolling shops and stores (OR 1.80, 95% CI 1.09-3.00) were significantly more likely to have their hypertension under control. In Brazil, those 70-75 were significantly less likely to have their hypertension under control compared to their younger counterparts. In Colombia, this was not observed. This paper highlights the importance of theory-based studies within unique Latin American contexts on hypertension and suggests novel opportunities for intervention.

背景:中等收入国家的老年人对高血压的认识和控制研究不足,对不同影响层次(从个人到社区)的认识和控制的研究有限。拉丁美洲对高血压的研究也被认为不足:本研究采用社会生态模型(SEM)来研究与巴西和哥伦比亚老年人高血压意识和控制有关的个人、人际、机构和社区因素。该研究确定了更有可能不了解自己病情和/或在控制高血压方面面临挑战的老年人群体:我们分析了国际老龄人口流动性研究(International Mobility in Aging Study)的数据,这些数据来自南美洲人口最多的两个国家的研究地点,对象是 803 名居住在社区的 65-74 岁的成年人。研究框架为社会生态模型。逻辑回归模型确定了与高血压认知和控制相关的因素:结论:高血压在两个样本中都很普遍(>70%),知晓率很高(>80%)。确诊受访者的血压控制率较低:巴西为 30%,哥伦比亚为 51%。社会生态模型中的各种因素与知晓率和控制率有关,但各国之间存在明显差异。患有糖尿病(OR 4.19,95%CI 1.64-10.71)和收入不足(OR:1.85,95%CI 1.03-3.31)的人更有可能意识到自己患有高血压。在哥伦比亚,没有参加社区活动的人比参加社区活动的人更不可能知道自己患有高血压。在巴西,情况正好相反。女性(OR 1.66,95%CI 1.12-2.46)和报告逛商店和商店的人群(OR 1.80,95%CI 1.09-3.00)明显更有可能控制住自己的高血压。在巴西,70-75 岁人群的高血压得到控制的可能性明显低于年轻人。在哥伦比亚,没有观察到这种情况。本文强调了在拉丁美洲独特的环境中对高血压进行基于理论的研究的重要性,并提出了新的干预机会。
{"title":"Socioecological Factors Associated with Hypertension Awareness and Control Among Older Adults in Brazil and Colombia: Correlational Analysis from the International Mobility in Aging Study.","authors":"Catherine M Pirkle, Ricardo Oliveira Guerra, Fernando Gómez, Emmanuelle Belanger, Tetine Sentell","doi":"10.5334/gh.1282","DOIUrl":"10.5334/gh.1282","url":null,"abstract":"<p><strong>Background: </strong>Hypertension awareness and control are understudied among older adults in middle-income countries, with limited work contextualizing awareness and control across layers of influence (individual to the community). Research on hypertension in Latin America is acknowledged as insufficient.</p><p><strong>Objectives: </strong>This study applies the socioecological model (SEM) to examine individual, interpersonal, institutional, and community factors related to hypertension awareness and control in older adults residing in Brazil and Colombia. It identifies groups of older adults more likely to be unaware of their condition and/or to have challenges achieving hypertension control.</p><p><strong>Methods: </strong>We analyzed International Mobility in Aging Study data of 803 community-dwelling adults 65-74 years from study sites in the two most populous countries in South America. The study framework was the socioecological model. Logistic regression models identified factors associated with hypertension awareness and control.</p><p><strong>Conclusions: </strong>Hypertension was prevalent in both samples (>70%), and awareness was high (>80%). Blood pressure control among diagnosed respondents was low: 30% in Brazil and 51% in Colombia. Factors across the socioecological model were associated with awareness and control, with notable differences across countries. Those with diabetes (OR 4.19, 95%CI 1.64-10.71) and insufficient incomes (OR: 1.85, 95%CI 1.03-3.31) were more likely to be aware of their hypertension. In Colombia, those reporting no community activity engagement were less likely to be aware compared to those reporting community activities. In Brazil, it was the opposite. Women (OR 1.66, 95%CI 1.12-2.46) and those reporting strolling shops and stores (OR 1.80, 95% CI 1.09-3.00) were significantly more likely to have their hypertension under control. In Brazil, those 70-75 were significantly less likely to have their hypertension under control compared to their younger counterparts. In Colombia, this was not observed. This paper highlights the importance of theory-based studies within unique Latin American contexts on hypertension and suggests novel opportunities for intervention.</p>","PeriodicalId":56018,"journal":{"name":"Global Heart","volume":"18 1","pages":"66"},"PeriodicalIF":3.0,"publicationDate":"2023-12-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10756159/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139076039","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effects of Behavioral Interventions for Salt Reduction on Blood Pressure and Urinary Sodium Excretion: A Systematic Review and Meta-Analysis of Randomized Controlled Trials 减盐行为干预对血压和尿钠排泄的影响:随机对照试验的系统回顾和元分析
IF 3.7 3区 医学 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2023-12-22 DOI: 10.5334/gh.1281
Ruilong Xun, Yusi Gao, Shiqi Zhen, Tao Mao, H. Xia, Hong Zhang, Guiju Sun
Hypertension is a prevalent cardiovascular condition, with excessive sodium intake being a significant risk factor. Various studies have investigated measures to reduce salt intake, including integrated lifestyle interventions and health education. However, the effectiveness of behavioral interventions focused solely on salt reduction remains unclear. This systematic review and meta-analysis aimed to investigate the effects of a behavioral intervention based on salt reduction on blood pressure and urinary sodium excretion. A comprehensive search of the Cochrane Central Register of Controlled Trials, EMBASE, PubMed, and Web of Science was conducted to identify relevant literature. Study and intervention characteristics were extracted for descriptive synthesis, and the quality of the included studies was assessed. A total of 10 studies, comprising 4,667 participants (3,796 adults and 871 children), were included. The interventions involved the provision of salt-restriction spoons or devices, salt-reduction education, self-monitoring devices for urinary sodium, and salt-reduction cooking classes. Meta-analysis results showed that behavioral interventions focused on salt reduction significantly reduced systolic blood pressure (SBP) (–1.17 mmHg; 95% CI, –1.86 to –0.49), diastolic blood pressure (DBP) (–0.58 mmHg; 95% CI, –1.07 to –0.08) and urinary sodium excretion (–21.88 mmol/24 hours; 95% CI, –32.12 to –11.64). These findings suggest that behavioral change interventions centered on salt reduction can effectively lower salt intake levels and decrease blood pressure levels. However, to enhance effectiveness, behavioral interventions for salt reduction should be combined with other salt-reduction strategies.
高血压是一种常见的心血管疾病,钠摄入量过高是一个重要的风险因素。多项研究调查了减少盐摄入量的措施,包括综合生活方式干预和健康教育。然而,仅以减少食盐摄入量为重点的行为干预措施的有效性仍不明确。本系统综述和荟萃分析旨在研究基于减盐的行为干预对血压和尿钠排泄的影响。我们对 Cochrane Central Register of Controlled Trials、EMBASE、PubMed 和 Web of Science 进行了全面检索,以确定相关文献。提取了研究和干预特征进行描述性综合,并对纳入研究的质量进行了评估。共纳入了 10 项研究,包括 4,667 名参与者(3,796 名成人和 871 名儿童)。干预措施包括提供限盐勺或装置、减盐教育、尿钠自我监测装置和减盐烹饪课程。Meta 分析结果表明,以减盐为重点的行为干预可显著降低收缩压(SBP)(-1.17 mmHg;95% CI,-1.86 至 -0.49)、舒张压(DBP)(-0.58 mmHg;95% CI,-1.07 至 -0.08)和尿钠排泄量(-21.88 mmol/24小时;95% CI,-32.12 至 -11.64)。这些研究结果表明,以减少食盐摄入量为核心的行为改变干预措施可以有效降低食盐摄入量,并降低血压水平。然而,为了提高效果,减盐行为干预应与其他减盐策略相结合。
{"title":"Effects of Behavioral Interventions for Salt Reduction on Blood Pressure and Urinary Sodium Excretion: A Systematic Review and Meta-Analysis of Randomized Controlled Trials","authors":"Ruilong Xun, Yusi Gao, Shiqi Zhen, Tao Mao, H. Xia, Hong Zhang, Guiju Sun","doi":"10.5334/gh.1281","DOIUrl":"https://doi.org/10.5334/gh.1281","url":null,"abstract":"Hypertension is a prevalent cardiovascular condition, with excessive sodium intake being a significant risk factor. Various studies have investigated measures to reduce salt intake, including integrated lifestyle interventions and health education. However, the effectiveness of behavioral interventions focused solely on salt reduction remains unclear. This systematic review and meta-analysis aimed to investigate the effects of a behavioral intervention based on salt reduction on blood pressure and urinary sodium excretion. A comprehensive search of the Cochrane Central Register of Controlled Trials, EMBASE, PubMed, and Web of Science was conducted to identify relevant literature. Study and intervention characteristics were extracted for descriptive synthesis, and the quality of the included studies was assessed. A total of 10 studies, comprising 4,667 participants (3,796 adults and 871 children), were included. The interventions involved the provision of salt-restriction spoons or devices, salt-reduction education, self-monitoring devices for urinary sodium, and salt-reduction cooking classes. Meta-analysis results showed that behavioral interventions focused on salt reduction significantly reduced systolic blood pressure (SBP) (–1.17 mmHg; 95% CI, –1.86 to –0.49), diastolic blood pressure (DBP) (–0.58 mmHg; 95% CI, –1.07 to –0.08) and urinary sodium excretion (–21.88 mmol/24 hours; 95% CI, –32.12 to –11.64). These findings suggest that behavioral change interventions centered on salt reduction can effectively lower salt intake levels and decrease blood pressure levels. However, to enhance effectiveness, behavioral interventions for salt reduction should be combined with other salt-reduction strategies.","PeriodicalId":56018,"journal":{"name":"Global Heart","volume":"16 3","pages":""},"PeriodicalIF":3.7,"publicationDate":"2023-12-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138947628","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Formative Evaluation and Adaptation of a Hypertension Extension for Community Health Outcomes Program for Healthcare Workers within the Federal Capital Territory, Nigeria. 尼日利亚联邦首都地区医疗保健工作者高血压社区健康结果扩展方案的形成性评估和调整。
IF 3 3区 医学 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2023-11-27 eCollection Date: 2023-01-01 DOI: 10.5334/gh.1277
Abigail S Baldridge, Nadia Goldstar, Grace C Bellinger, Abigail T DeNoma, Ikechukwu A Orji, Gabriel L Shedul, Rosemary C B Okoli, Nanna R Ripiye, Adaora Odukwe, Olabisi Dabiri, L Nneka Mobisson, Dike B Ojji, Mark D Huffman, Namratha R Kandula, Lisa R Hirschhorn

Background: The Extension for Community Health Outcomes (ECHO) model has been used extensively to link care providers in rural communities with experts with the aim of improving local patient care.

Objective: The aim of this qualitative research study was to assess the feasibility, acceptability, perceived needs, and contextual factors to guide implementation of a hypertension focused ECHO program for Community Health Extension Workers (CHEWs) in the Federal Capital Territory, Nigeria.

Methods: From September 2020 to December 2020, key informant interviews were performed with seven global organizations (hubs) providing ECHO training focused on cardiovascular disease or nephrology to identify contextual factors and implementation strategies used by each hub. In February 2022, seven focus group discussions were performed with 42 frontline healthcare workers in the Federal Capital Territory to inform local adaptation of a hypertension ECHO program. Directed content analysis identified major themes which were mapped to the Consolidated Framework for Implementation Research. Qualitative analyses were performed using Dedoose, and results were synthesized using the Implementation Research Logic Model.

Results: We found both barriers and facilitators across the Consolidated Framework for Implementation Research domains that mapped to a number of constructs in each one. The results of these analyses confirmed that the core components of the ECHO model are a feasible and appropriate intervention for hypertension education of healthcare workers. However, implementing the ECHO program within the Federal Capital Territory may require strategies such as utilizing communications resources effectively, developing incentives to motivate initial participation, and providing rewards or recognition for ongoing engagement.

Conclusions: These results provide valuable formative insights to guide implementation of our proposed hypertension ECHO program for CHEWs in the Federal Capital Territory, Nigeria. This information was used for key decisions around: 1) scope and content of training, 2) format and frequency, 3) selection of implementation strategies, and 4) building a community of practice.

背景:扩大社区卫生成果(ECHO)模式已被广泛用于将农村社区的护理提供者与专家联系起来,目的是改善当地患者的护理。目的:本定性研究的目的是评估可行性、可接受性、感知需求和背景因素,以指导尼日利亚联邦首都地区社区卫生推广工作者(CHEWs)实施以高血压为重点的ECHO项目。方法:从2020年9月到2020年12月,对7个提供心血管疾病或肾脏病学ECHO培训的全球组织(中心)进行了关键信息提供者访谈,以确定每个中心使用的背景因素和实施策略。2022年2月,在联邦首都地区与42名一线医护人员进行了7次焦点小组讨论,以告知当地对高血压ECHO项目的适应情况。有针对性的内容分析确定了主要主题,并将其纳入实施研究综合框架。使用Dedoose进行定性分析,并使用实施研究逻辑模型对结果进行综合。结果:我们在实施研究领域的统一框架中发现了障碍和促进因素,这些障碍和促进因素映射到每个领域的许多构造。这些分析的结果证实了ECHO模型的核心组成部分是一种可行和适当的干预高血压教育的医护人员。然而,在联邦首都地区实施ECHO项目可能需要一些策略,如有效利用通信资源,制定激励措施来激励最初的参与,并为持续参与提供奖励或认可。结论:这些结果为指导在尼日利亚联邦首都地区实施我们提出的CHEWs高血压ECHO计划提供了有价值的形成性见解。这些信息用于以下方面的关键决策:1)培训的范围和内容,2)形式和频率,3)实施策略的选择,以及4)建立实践社区。
{"title":"Formative Evaluation and Adaptation of a Hypertension Extension for Community Health Outcomes Program for Healthcare Workers within the Federal Capital Territory, Nigeria.","authors":"Abigail S Baldridge, Nadia Goldstar, Grace C Bellinger, Abigail T DeNoma, Ikechukwu A Orji, Gabriel L Shedul, Rosemary C B Okoli, Nanna R Ripiye, Adaora Odukwe, Olabisi Dabiri, L Nneka Mobisson, Dike B Ojji, Mark D Huffman, Namratha R Kandula, Lisa R Hirschhorn","doi":"10.5334/gh.1277","DOIUrl":"10.5334/gh.1277","url":null,"abstract":"<p><strong>Background: </strong>The Extension for Community Health Outcomes (ECHO) model has been used extensively to link care providers in rural communities with experts with the aim of improving local patient care.</p><p><strong>Objective: </strong>The aim of this qualitative research study was to assess the feasibility, acceptability, perceived needs, and contextual factors to guide implementation of a hypertension focused ECHO program for Community Health Extension Workers (CHEWs) in the Federal Capital Territory, Nigeria.</p><p><strong>Methods: </strong>From September 2020 to December 2020, key informant interviews were performed with seven global organizations (hubs) providing ECHO training focused on cardiovascular disease or nephrology to identify contextual factors and implementation strategies used by each hub. In February 2022, seven focus group discussions were performed with 42 frontline healthcare workers in the Federal Capital Territory to inform local adaptation of a hypertension ECHO program. Directed content analysis identified major themes which were mapped to the Consolidated Framework for Implementation Research. Qualitative analyses were performed using Dedoose, and results were synthesized using the Implementation Research Logic Model.</p><p><strong>Results: </strong>We found both barriers and facilitators across the Consolidated Framework for Implementation Research domains that mapped to a number of constructs in each one. The results of these analyses confirmed that the core components of the ECHO model are a feasible and appropriate intervention for hypertension education of healthcare workers. However, implementing the ECHO program within the Federal Capital Territory may require strategies such as utilizing communications resources effectively, developing incentives to motivate initial participation, and providing rewards or recognition for ongoing engagement.</p><p><strong>Conclusions: </strong>These results provide valuable formative insights to guide implementation of our proposed hypertension ECHO program for CHEWs in the Federal Capital Territory, Nigeria. This information was used for key decisions around: 1) scope and content of training, 2) format and frequency, 3) selection of implementation strategies, and 4) building a community of practice.</p>","PeriodicalId":56018,"journal":{"name":"Global Heart","volume":"18 1","pages":"64"},"PeriodicalIF":3.0,"publicationDate":"2023-11-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10691284/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138479366","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Global Heart
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1